Page 5,363«..1020..5,3625,3635,3645,365..5,3705,380..»

RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States

Posted: Published on May 3rd, 2013

GERMANTOWN, Md., May 2, 2013 /PRNewswire/ -- RNL BIO, a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic and other indications, has announced that it has filed an Investigational New Drug application (IND) with the Food and Drug Administration (FDA) to begin clinical trials with its adipose-derived stem cell product, termed RNL-JointStem, for the treatment of osteoarthritis (OA). Assuming approval of the IND by the Center for Biologics Evaluation and Research (CBER) at the FDA, RNL BIO plans to initiate its double-blinded, randomized, positive-control Phase II clinical trial during the third quarter of 2013 in Sugarland, Texas. Dr. Jason Dragoo of Stanford University and Dr. David Alan Fisher of Indiana University acted as reviewers and completed revision of the protocol now under evaluation by the FDA. Phase I and Phase II clinical trials of RNL-JointStem have already been completed under the authority of the Korean Food and Drug Administration (KFDA). "We are excited about filing an IND for RNL-JointStem because it brings us closer to a clinical trial with RNL-JointStem in the United States," said Jeong-Chan Ra, CEO and Chairman of RNL BIO. "Our goal for this trial is … Continue reading →

Comments Off on RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States

Single Particle Tracking for Studying Intracellular Nanomedicine Trafficking – Video

Posted: Published on May 3rd, 2013

Single Particle Tracking for Studying Intracellular Nanomedicine Trafficking By: ICTASVT … Continue reading →

Comments Off on Single Particle Tracking for Studying Intracellular Nanomedicine Trafficking – Video

Trimel to Report First Quarter 2013 Results and Host Investor Call

Posted: Published on May 3rd, 2013

TORONTO, ONTARIO--(Marketwired - May 2, 2013) - Trimel Pharmaceuticals Corporation (TRL.TO) will report its first quarter financial results for the period ended March 31, 2013 on Wednesday, May 8, 2013 after the market closes. Management of the Company will host a conference call to discuss these results and update investors on the status of its business on Thursday, May 9, 2013, at 8:30 a.m. Eastern Daylight Time. To access the call live, please dial 416-340-2216 (Toronto), 1-866-226-1792 (Canada and U.S.) or 1- 800-9559-6849 (International). Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 7:00 p.m. Eastern Daylight Time on Thursday, May 16, 2013 by dialing 905-694-9451 (Toronto), 1-800-408-3053 (Canada and U.S.) or 00-800-3366-3052 (International), using access code: 3086288#. For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or via email at ir@trimelpharmaceuticals.com. About Trimel Trimel Pharmaceuticals Corporation (TRL.TO) - Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. A New Drug Application for CompleoTRT, a product utilizing Trimel's licensed bioadhesive intranasal gel technology, has been filed … Continue reading →

Posted in Male Sexual Dysfunction | Comments Off on Trimel to Report First Quarter 2013 Results and Host Investor Call

Class-Action Lawsuit on Propecia Erectile Dysfunction Approved: Now, AttorneyOne Can Provide Advice

Posted: Published on May 3rd, 2013

San Diego, CA (PRWEB) May 03, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Propecia Lawsuit. On March 28, 2013 B.C. Judge approved a class action lawsuit filed by a man in Supreme Court of British Columbia (Docket S110437) alleging sexual dysfunction from Propecia. Propecia is a pill, manufactured by Merck, for use in males only and indicated for the treatment of male pattern hair loss. It was approved by the FDA in 1997. In the lawsuit plaintiff claims he was prescribed Propecia in 2008 at the age of 25 and months after using the drug he experienced inability to maintain an erection. According to court data updated on March 5, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), there are 140 actions pending in the Propecia MDL (U.S. District Court, Eastern District of New York, MDL 2331 - IN RE: Propecia (Finasteride) Products Liability Litigation). Plaintiffs claim that Merck failed to warn on Propecia side effects that could cause permanent and devastating sexual dysfunction. Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an … Continue reading →

Posted in Male Sexual Dysfunction | Comments Off on Class-Action Lawsuit on Propecia Erectile Dysfunction Approved: Now, AttorneyOne Can Provide Advice

Testosterone for Men – Video

Posted: Published on May 3rd, 2013

Testosterone for Men This week we're focusing on the men! Don't let age emasculate you...maintain your youthful vigor and vitality! In this video, I go over some natural suppleme... By: Barbara Hoffman … Continue reading →

Posted in Testosterone | Comments Off on Testosterone for Men – Video

Increase testosterone:Sleep In A Cold, Dark Room – Video

Posted: Published on May 3rd, 2013

Increase testosterone:Sleep In A Cold, Dark Room Increase testosterone and improve sleep Video reveals the best diet to lose weight http://www.thephysiqueformula.com Want to build muscle? Hire jimmy http://www.jimmysmithtraining.com What... By: jimmysmithtraining … Continue reading →

Posted in Testosterone | Comments Off on Increase testosterone:Sleep In A Cold, Dark Room – Video

WWE '13 – HGH Clan OWNING these T-Rashy ass SPAMMERS – Video

Posted: Published on May 3rd, 2013

WWE'13 - HGH Clan OWNING these T-Rashy ass SPAMMERS HGH. By: HaterzGoneHate100 … Continue reading →

Posted in HGH | Comments Off on WWE '13 – HGH Clan OWNING these T-Rashy ass SPAMMERS – Video

PFT: HGH use reportedly rampant across league

Posted: Published on May 3rd, 2013

Getty Images The one we continue to know about the honor system is that the honor system doesnt work. The NFL bans HGH use. The NFL still has no test in place to determine whether players are complying with this rule. Not surprisingly, players still ignore the rule. Dan Patrick mentions from time to time that a starting NFL quarterback privately told Patrick within the past two or three years that 60 percent of the league uses HGH. Tyler Dunne of the Milwaukee Journal Sentinel reports that HGH use is rampant. Its like clockwork nowadays, an unnamed NFC starter told Dunne. Not tested and its easy to get. Nowadays, dude? In 2013? [Expletive] yeah. Im just being real. The unnamed player estimates that 10-15 players per team use the substance, which puts the percentage in the range of 18-28. The NFL and NFLPA agreed in 2011 that blood testing for HGH will be implemented. Two full football seasons later, blood testing for HGH has not yet commenced, due to a lingering impasse regarding the manner in which testing will happen. Periodically, members of Congress huff and puff regarding the perception that the NFLPA is dragging its feet. But the NFL … Continue reading →

Posted in HGH | Comments Off on PFT: HGH use reportedly rampant across league

HGH Human Growth Hormone) Energizer – Video

Posted: Published on May 3rd, 2013

HGH Human Growth Hormone) Energizer http://mhlnk.com/2D03D243 HGH Energizer is a powerful health supplement that can help you replenish the human growth hormones that your body needs. research ... By: rodric3080 … Continue reading →

Posted in Human Growth Hormone | Comments Off on HGH Human Growth Hormone) Energizer – Video

Wealthy Ontario seniors to pay more for prescriptions: budget

Posted: Published on May 3rd, 2013

Ontarios wealthiest senior citizens could be paying hundreds of dollars more out of pocket for prescription drugs every year under the Liberal governments proposed budget. Most seniors across the province currently have a co-pay of $6.11 per prescription with a $100 yearly deductible. The co-pay would remain stable under the plan, which was released Thursday, but the deductible could increase considerably for individual seniors with incomes over $100,000, or family incomes of more than $160,000. Seniors in those categories would see their deductible rise by an amount equivalent to 3 per cent of their income over the thresholds, according to government officials who briefed reporters on the budget. For example, the deductible for a single senior citizen with an income of $120,000 would jump to $700, an increase of $600, or 3 per cent of $20,000. How much revenue the initiative would generate for the cash-strapped province has yet to be calculated, the officials said, but it is anticipated that the increase would affect 5 per cent of the senior population. The initiative is slated to take effect in August of 2014. Health Minister Deb Matthews cast the increase as essential to sustaining universal health care and said the majority … Continue reading →

Posted in Prescriptions | Comments Off on Wealthy Ontario seniors to pay more for prescriptions: budget

Page 5,363«..1020..5,3625,3635,3645,365..5,3705,380..»